查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1994193

合约研究与生产服务市场：2026-2032年全球市场预测（按服务类型、技术、治疗领域、应用和最终用户划分）

Contract Research & Manufacturing Services Market by Service Type, Technology, Therapeutic Area, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，合约研究和製造服务市场价值将达到 765.2 亿美元，到 2026 年将成长到 834 亿美元，到 2032 年将达到 1507.1 亿美元，复合年增长率为 10.16%。

主要市场统计数据
基准年 2025 765.2亿美元
预计年份：2026年 834亿美元
预测年份 2032 1507.1亿美元
复合年增长率 (%) 10.16%

前瞻性的介绍概述了定义现代合约研究和製造服务的策略挑战、营运趋势和相关人员的期望。

合约研发和製造服务业处于科学创新、监管和商业策略的交汇点。来自产业界、学术界和政府的相关人员日益寻求能够缩短研发週期、同时保证品质和合规性的全面解决方案。在此背景下，供应商的角色正在从单纯的贸易伙伴转变为策略合作伙伴，他们致力于降低专案风险并加速研发进程。

客户对整合合作伙伴模式的需求正在推动产业发生显着变革，这种模式能够加速技术采用、监管适应和转化研究的成功。

受技术成熟、法规演变和商业化策略转变的驱动，合约研究和生产服务产业格局正在经历变革性变化。先进的分析、机器学习和自动化技术正在重塑实验室工作流程和製程开发，从而实现更高的通量和更可预测的决策。因此，将数位化工具整合到端到端开发平臺中的企业能够提高可重复性，并加快从药物发现到正式开发的过渡。

美国于 2025 年实施的关税措施对营运和策略产生了累积影响，促使我们整个服务网络进行供应链调整、提高成本透明度并製定紧急时应对计画。

2025年新关税和贸易措施的实施对全球生命科学价值链的营运规划和供应商关係产生了重大影响。为此，製造商和研发服务供应商正在重新思考筹资策略，重新评估供应商合同，并寻找能够降低成本波动风险、同时维持关键生产能力的替代采购途径。这些调整措施凸显了供应商网路多元化和扩大区域采购对于管理关税不确定性带来的营运风险的重要性。

详细的细分洞察揭示了服务类型、技术选择、治疗领域重点、应用要求和最终用户概况如何决定合作伙伴选择和交付模式。

基于细分市场的洞察揭示了相关人员在评估合作伙伴时应考虑的差异化价值提案和营运重点。从服务类型来看，服务能力涵盖咨询和开发、製造以及研发等领域，每个细分市场对人员、品质系统和资本投入的要求各不相同。专注于咨询和开发的供应商通常强调科学咨询能力和专案设计，而专注于製造的机构则优先考虑流程稳健性、产能运转率和法规遵循。

从区域观点全面分析美洲、欧洲、中东和非洲以及亚太地区的生产能力、监管差异和合作模式，这些因素会影响战略部署。

区域趋势持续影响美洲、欧洲、中东和非洲以及亚太地区的产能、监管复杂性和伙伴关係模式，每个地区都面临各自独特的营运权衡和战略机会。在美洲，统一的监管流程和先进的製造生态系统支持着一体化服务模式和快速转化项目，同时也吸引了对专业生技药品和细胞疗法能力的投资。纵观各地区，欧洲、中东和非洲（EMEA）地区呈现出管理体制和准入途径多元化的格局，这为拥有强大的本地监管能力和成熟临床网络的供应商创造了有利环境。

这项关键的竞争考察和策略性企业洞察揭示了平台投资、伙伴关係策略和人才获取重点如何决定合约研究和製造服务领域的领导地位。

该领域主要企业的竞争地位反映了它们在平台投资、服务广度和地理覆盖范围等方面的策略重点差异。一些企业优先考虑深厚的专业知识和专有平台，这些平台能够在生物製剂製程开发和先进分析表征等领域提供高价值和技术差异化优势。而其他企业则专注于服务广度和规模，透过整合药物发现、开发和生产能力，为复杂的专案提供一站式解决方案。

为领导者提供切实可行的策略建议，以增强韧性、加速数位转型，并使服务交付与客户的策略重点和监管现实保持一致。

产业领导企业应采取一系列切实可行的措施来增强韧性、实现服务差异化，并更紧密地满足客户需求。首先，企业需要加快将数位化工具和数据标准整合到实验室和生产营运中，以提高可重复性并实现预测性製程控制。在进行技术现代化的同时，也应增加对员工培训的投入，以确保分析结果能快速可靠地转化为营运决策。

采用透明的混合方法调查方法，将对高阶主管的直接访谈与系统性的二次分析结合，以检验见解并确保可操作的相关性。

为确保研究的深度和有效性，本分析采用了一种混合方法，将结构化的质性研究与系统性的二手资料研究结合。主要资料来源包括对高阶主管、研发负责人和供应链专家的访谈，从而获得关于营运挑战、策略重点和伙伴关係模式的第一手观点。二手资料来源包括同侪审查文献、监管指导文件、专利申请和上市公司揭露资讯。透过综合这些资料，我们为主题结论建立了可靠的证据基础。

摘要强调营运卓越、数位化和咨询型伙伴关係模式的策略整合将决定未来的成功。

总之，合约研究与生产服务 (CR&M) 产业正处于一个关键的转折点，其特点是技术快速变革、监管预期不断变化以及客户对整合式咨询型伙伴关係关係的需求日益增长。那些在数位化平台、人才培养和供应链韧性方面进行合理投资的机构，将更有能力应对不确定性，并在各个治疗领域建立策略联盟。此外，能够提供清晰、可审计的数据并协调不同司法管辖区的品质体系，正日益成为一项重要的竞争优势，也是建立长期客户信任的基础。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 合约研究与製造服务市场：依服务类型划分

  • 咨询
  • 发展
  • 製造业
  • 调查

第九章 合约研究与製造服务市场：依技术划分

  • 生物资讯学
  • 组合化学
  • 高通量筛检
  • 光谱学

第十章：合约研究与製造服务市场：依治疗领域划分

  • 循环系统
  • 内分泌疾病
  • 感染疾病
  • 肿瘤学

第十一章 合约研究与製造服务市场：依应用领域划分

  • 生物製药开发
  • 药物发现
  • 配方开发
  • 製程开发

第十二章 合约研究与製造服务市场：依最终用户划分

  • 学术和研究机构
  • 生技公司
  • 医疗设备製造商
  • 製药公司

第十三章 合约研究与製造服务市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 合约研究与製造服务市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 合约研究与製造服务市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国合约研究与製造服务市场

第十七章：中国的合约研究与製造服务市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AGC Biologics
  • Avid Bioservices, Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • Envigo
  • Eurofins Scientific SE
  • Fujifilm Diosynth Biotechnologies
  • Gubra A/S
  • ICON plc
  • IQVIA Holdings Inc.
  • LabCorp Drug Development
  • Lonza Group Ltd
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development, LLC（PPD）
  • Recipharm AB
  • Samsung Biologics Co., Ltd.
  • Sartorius Stedim Biotech SA
  • Siegfried AG
  • Syneos Health, Inc.
  • TFBS Bioscience Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
Product Code: MRR-1A1A064C0470

The Contract Research & Manufacturing Services Market was valued at USD 76.52 billion in 2025 and is projected to grow to USD 83.40 billion in 2026, with a CAGR of 10.16%, reaching USD 150.71 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 76.52 billion
Estimated Year [2026] USD 83.40 billion
Forecast Year [2032] USD 150.71 billion
CAGR (%) 10.16%

A forward-looking introduction framing the strategic imperatives, operational dynamics, and stakeholder expectations that define modern contract research and manufacturing services

The contract research and manufacturing services sector operates at the intersection of scientific innovation, regulatory scrutiny, and commercial strategy. Stakeholders across industry, academia, and government increasingly demand integrated solutions that shorten development timelines while maintaining quality and regulatory compliance. In this context, service providers are evolving from transactional vendors into strategic partners that contribute to program de-risking and accelerated development pathways.

Emerging technological capabilities and shifting client expectations are reinforcing the need for versatile operating models. Organizations are balancing investments in specialized platforms with flexible capacity to serve diverse therapeutic programs. This introduction frames the critical themes explored in the subsequent sections, emphasizing a pragmatic view of risk management, collaborative engagement models, and the operational imperatives that will determine competitive differentiation in the near to medium term.

Compelling landscape shifts driven by technology adoption, regulatory adaptation, and client demand for integrated partner models that accelerate translational success

The landscape of contract research and manufacturing services is undergoing transformative shifts driven by technological maturation, regulatory evolution, and changing commercialization strategies. Advanced analytics, machine learning, and automation are reshaping laboratory workflows and process development, enabling higher throughput and more predictive decision-making. Consequently, organizations that integrate digital tools into end-to-end development pipelines are realizing improved reproducibility and faster handoffs from discovery to formal development stages.

Concurrently, regulatory frameworks are adapting to novel modalities and accelerated approval pathways, placing a premium on demonstrable quality and data integrity. This regulatory evolution has prompted service providers to embed compliance expertise earlier in program design and to offer harmonized documentation practices that support multi-jurisdictional submissions. In parallel, client expectations have shifted toward partner models that combine technical execution with strategic advisory capabilities, leading to bundled service offerings that span discovery, formulation, process development, and scale-up. Taken together, these trends are compelling firms to invest in both technological platforms and consultative talent, so they can deliver predictable outcomes across increasingly complex therapeutic portfolios.

Cumulative operational and strategic consequences of United States tariff actions in 2025 driving supply chain rebalancing, cost transparency, and contingency planning across service networks

The introduction of new tariffs and trade measures in 2025 has materially affected operational planning and supplier relationships across global life sciences supply chains. Manufacturers and research service providers have responded by reassessing sourcing strategies, re-evaluating supplier contracts, and identifying alternative procurement routes that can mitigate cost volatility while preserving critical capacity. These adaptations have emphasized the value of diversified supplier networks and increased regional sourcing to manage the operational exposure created by tariff uncertainty.

In parallel, clients have prioritized transparency around landed costs and supply chain continuity, prompting service providers to present more granular cost breakdowns and contingency plans. Firms with flexible manufacturing footprints and multi-jurisdictional regulatory expertise have gained an advantage when clients seek rapid adjustments to development or manufacturing plans. Furthermore, organizations are increasingly embedding tariff scenario planning into project timelines and capital allocation exercises, ensuring that procurement and program leadership collaborate closely to preserve timelines and maintain regulatory alignment despite evolving trade constraints.

In-depth segmentation insights illuminating how service types, technology choices, therapeutic focus, application requirements, and end-user profiles determine partner selection and delivery models

Segmentation-driven insights reveal differentiated value propositions and operational priorities that stakeholders should consider when evaluating partners. When viewed through the lens of service type, capabilities span a continuum from consulting and development to manufacturing and research, with each segment demanding distinct talent, quality systems, and capital intensity. Providers focusing on consulting and development typically emphasize scientific advisory capabilities and program design, whereas manufacturing-focused organizations prioritize process robustness, capacity utilization, and regulatory readiness.

Technology-based segmentation underscores how platform choices shape service delivery. Bioinformatics, combinatorial chemistry, high-throughput screening, and spectroscopy each contribute unique data streams and workflow needs; integrating these platforms requires interoperable data architectures and cross-disciplinary expertise. Therapeutic area segmentation highlights clinical and regulatory nuances across cardiovascular, endocrine disease, infectious disease, and oncology programs, informing required safety assessments and specialized process controls. Application-focused segmentation draws attention to the differing priorities of biologics development, drug discovery, formulation development, and process development, with each application imposing its own timeline, analytical demand, and manufacturing constraints. Finally, end-user segmentation recognizes the diverse buying behaviors and operational objectives of academic and research institutes, biotechnology companies, medical device companies, and pharmaceutical companies, whereby academic partners may prioritize flexibility and novel science, small biotech may emphasize speed to proof-of-concept, and larger pharma partners often require scale, documented control strategies, and integrated regulatory support.

Comprehensive regional perspectives on capacity, regulatory variation, and collaborative models across the Americas, Europe, Middle East & Africa, and Asia-Pacific influencing strategic deployment

Regional dynamics continue to influence capacity, regulatory complexity, and partnership models across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography presenting distinct operational trade-offs and strategic opportunities. In the Americas, centralized regulatory pathways and advanced manufacturing ecosystems often support integrated service models and rapid translational programs, while also attracting investment in specialized biologics and cell therapy capabilities. Transitioning across regions, the Europe, Middle East & Africa cluster presents a mosaic of regulatory regimes and access pathways that favor providers with strong local regulatory affairs capabilities and established clinical networks.

Asia-Pacific has emerged as a critical node for both development and manufacturing due to investments in talent, scale capacity, and cost-competitive production. As a result, many organizations pursue hybrid strategies that combine regional development hubs with localized manufacturing to optimize speed-to-market and manage regulatory submissions in multiple jurisdictions. Across all regions, cross-border collaboration and harmonization efforts are increasing, which encourages service providers to standardize quality systems and to offer coordinated regulatory support that reduces duplicative work and accelerates global program timelines.

Key competitive and strategic company insights revealing how platform investments, partnership strategies, and talent priorities define leadership in contract research and manufacturing services

Competitive positioning among leading firms in the sector reflects differing strategic emphases on platform investments, service breadth, and geographic reach. Some organizations prioritize deep specialization and proprietary platforms that deliver high-value, technical differentiation in areas such as biologics process development or advanced analytical characterization. Other firms emphasize breadth of service and scale, bundling discovery, development, and manufacturing capabilities to offer a single-source solution for complex programs.

Partnership strategies are increasingly common, as firms form alliances with technology vendors, academic centers, and contract partners to close capability gaps and to accelerate time to clinic. Talent acquisition and retention remain central competitive levers; companies that invest in cross-functional scientists and regulatory experts can more effectively support customers through complex development pathways. Additionally, firms that cultivate transparent client communication practices and robust quality systems tend to secure longer-term collaborations, as clients prioritize predictability and regulatory readiness when selecting partners.

Actionable strategic recommendations for leaders to enhance resilience, accelerate digital transformation, and align service delivery with client strategic priorities and regulatory realities

Industry leaders should adopt a set of pragmatic, actionable measures to strengthen resilience, differentiate their offerings, and align more closely with client needs. First, companies should accelerate integration of digital tools and data standards into laboratory and manufacturing operations to enhance reproducibility and enable predictive process control. This technical modernization should be accompanied by investments in workforce training so that teams can translate analytic outputs into operational decisions quickly and reliably.

Second, firms should formalize multi-scenario supply chain planning that anticipates tariff shifts, regulatory variations, and capacity constraints; by doing so, they can reduce program disruption and improve cost visibility for clients. Third, service providers should expand consultative capabilities that embed regulatory and commercial strategy into project design, thereby delivering more strategic value than project execution alone. Finally, organizations should pursue selective partnerships to access niche technologies or regional capacity, while maintaining a rigorous governance framework to ensure quality alignment and seamless data transfer across collaborative arrangements.

Transparent mixed-method research methodology combining primary executive interviews and systematic secondary analysis to validate insights and ensure practical relevance

The research underpinning this analysis used a mixed-method approach that combined structured qualitative inquiry with systematic secondary research to ensure depth and validity. Primary inputs included interviews with senior executives, R&D leaders, and supply chain specialists who provided firsthand perspectives on operational challenges, strategic priorities, and partnership models. Secondary inputs comprised peer-reviewed literature, regulatory guidance documents, patent filings, and public company disclosures, which together established a robust evidentiary basis for thematic conclusions.

Data synthesis emphasized triangulation to reduce single-source bias, and analytic frameworks were applied to map capabilities across service, technology, therapeutic, application, and end-user dimensions. Wherever possible, findings were corroborated through multiple independent sources and validated with industry practitioners to ensure practical relevance. The methodology prioritized transparency in assumptions and traceability of insights to source material, thereby facilitating confident interpretation and application by decision-makers.

Concluding synthesis emphasizing the strategic convergence of operational excellence, digital enablement, and consultative partnership models that will define future success

In closing, the contract research and manufacturing services sector is at a pivotal moment characterized by rapid technological change, evolving regulatory expectations, and heightened client demand for integrated, consultative partnerships. Organizations that align investments in digital platforms, talent development, and supply chain resilience will be better positioned to navigate uncertainty and to capture strategic collaborations across therapeutic areas. Moreover, the ability to present clear, auditable data and to harmonize quality systems across jurisdictions is increasingly a competitive differentiator that underpins long-term client trust.

Looking ahead, success will favor firms that combine operational excellence with advisory capabilities, enabling clients to progress complex programs more predictably. By focusing on interoperability of data systems, rigorous scenario planning, and selective partnerships for capability expansion, stakeholders can create more adaptable, value-driven service models that respond effectively to scientific and regulatory change.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Contract Research & Manufacturing Services Market, by Service Type

  • 8.1. Consulting
  • 8.2. Development
  • 8.3. Manufacturing
  • 8.4. Research

9. Contract Research & Manufacturing Services Market, by Technology

  • 9.1. Bioinformatics
  • 9.2. Combinatorial Chemistry
  • 9.3. High-Throughput Screening
  • 9.4. Spectroscopy

10. Contract Research & Manufacturing Services Market, by Therapeutic Area

  • 10.1. Cardiovascular
  • 10.2. Endocrine disease
  • 10.3. Infectious disease
  • 10.4. Oncology

11. Contract Research & Manufacturing Services Market, by Application

  • 11.1. Biologics Development
  • 11.2. Drug Discovery
  • 11.3. Formulation Development
  • 11.4. Process Development

12. Contract Research & Manufacturing Services Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Medical Device Companies
  • 12.4. Pharmaceutical Companies

13. Contract Research & Manufacturing Services Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Contract Research & Manufacturing Services Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Contract Research & Manufacturing Services Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Contract Research & Manufacturing Services Market

17. China Contract Research & Manufacturing Services Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AGC Biologics
  • 18.6. Avid Bioservices, Inc.
  • 18.7. Boehringer Ingelheim International GmbH
  • 18.8. Cambrex Corporation
  • 18.9. Catalent, Inc.
  • 18.10. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 18.11. Envigo
  • 18.12. Eurofins Scientific SE
  • 18.13. Fujifilm Diosynth Biotechnologies
  • 18.14. Gubra A/S
  • 18.15. ICON plc
  • 18.16. IQVIA Holdings Inc.
  • 18.17. LabCorp Drug Development
  • 18.18. Lonza Group Ltd
  • 18.19. Medpace Holdings, Inc.
  • 18.20. Parexel International Corporation
  • 18.21. Pharmaceutical Product Development, LLC (PPD)
  • 18.22. Recipharm AB
  • 18.23. Samsung Biologics Co., Ltd.
  • 18.24. Sartorius Stedim Biotech S.A.
  • 18.25. Siegfried AG
  • 18.26. Syneos Health, Inc.
  • 18.27. TFBS Bioscience Inc.
  • 18.28. Thermo Fisher Scientific Inc.
  • 18.29. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ENDOCRINE DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ENDOCRINE DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ENDOCRINE DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOLOGICS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOLOGICS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOLOGICS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY FORMULATION DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY FORMULATION DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 151. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)